Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2021

Jan 14, 2021

33298_dirs_2021-01-14_fa44e338-d98f-4ecc-8a97-59b6087dc9ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-01-05

Reporting Person: Hussey Bryant Patrick (Chief Digital Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options to purchase shares of Common Stock $ Common Stock, par value $0.001 (200000) Direct

Footnotes

F1: Pursuant to the terms of the employment agreement, by and between Mr. Hussey and the Issuer, on January 8, 2021 (the "Effective Date"), Mr. Hussey was granted stock options to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.50 per share (the "Stock Options"). The Stock Options are scheduled to vest in equal monthly tranches, based on the passage of time, over the 36 months following the approval of the Effective Date.